OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to Its Scientific Advisory Board
23 févr. 2023 02h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company developing OK-101 to treat dry eye disease...